Method of administering a thymosin alpha 1 peptide

Details Method of administering a thymosin alpha 1 peptide Method of administering a thymosin alpha 1 peptide

A - Human Necessities

61

K

A61K 38/22 (2006.01) A61K 38/04 (2006.01) C07K 14/575 (2006.01)

Patent

CA 2464307

A Thymosin alpha 1 (TA1) peptide is administered to a patient in need of immune stimulation so as to substantially continuously maintain an immune stimulating-effective amount of the TA1 peptide in the patient. The administration method may be by continuous infusion.

L'invention concerne un peptide alpha 1 (TA1) de la thymosine administré à un patient nécessitant une stimulation immune, afin de maintenir pratiquement continuellement une portée efficace de la stimulation immune du peptide TA1 chez le patient. La méthode d'administration peut se faire par infusion continue.

Affiliated with

Also associated with

Rating

Method of administering a thymosin alpha 1 peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of administering a thymosin alpha 1 peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of administering a thymosin alpha 1 peptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1825959